BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12691818)

  • 1. Inhibitory effects of 2-mercaptoethane sulfonate and 6-phenylhexyl isothiocyanate on urinary bladder tumorigenesis in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Nishikawa A; Morse MA; Chung FL
    Cancer Lett; 2003 Apr; 193(1):11-6. PubMed ID: 12691818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats.
    Hirose M; Yamaguchi T; Kimoto N; Ogawa K; Futakuchi M; Sano M; Shirai T
    Int J Cancer; 1998 Aug; 77(5):773-7. PubMed ID: 9688312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of N-n-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in rats by administration of disulfiram in the diet.
    Irving CC; Tice AJ; Murphy WM
    Cancer Res; 1979 Aug; 39(8):3040-3. PubMed ID: 455288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylsalicylic acid inhibition of n-butyl-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats.
    Klän R; Knispel HH; Meier T
    J Cancer Res Clin Oncol; 1993; 119(8):482-5. PubMed ID: 8509438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemopreventive efficacy of arylalkyl isothiocyanates and N-acetylcysteine for lung tumorigenesis in Fischer rats.
    Chung FL; Kelloff G; Steele V; Pittman B; Zang E; Jiao D; Rigotty J; Choi CI; Rivenson A
    Cancer Res; 1996 Feb; 56(4):772-8. PubMed ID: 8631012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain differences in mice with invasive bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Ohtani M; Kakizoe T; Sato S; Sugimura T; Fukushima S
    J Cancer Res Clin Oncol; 1986; 112(2):107-10. PubMed ID: 3771618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of urinary bladder tumorigenesis by carcinogen-exposed stroma.
    Uchida K; Samma S; Momose H; Kashihara N; Rademaker A; Oyasu R
    J Urol; 1990 Mar; 143(3):618-21. PubMed ID: 2304182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of disulfiram on the metabolism of the urinary bladder carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine in the rat.
    Irving CC; Daniel DS
    Carcinogenesis; 1987 Sep; 8(9):1309-15. PubMed ID: 3113755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed development of bladder cancer in male SD rats induced with N-nitroso-N-butyl-N-(4-hydroxybutyl)amine following concomitant administration of sodium 2-mercaptoethane sulfonate.
    Berger MR; Schmähl D
    Cancer Lett; 1986 Sep; 32(3):313-21. PubMed ID: 3094932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat urinary bladder carcinogenesis by alpha-difluoromethylornithine.
    Homma Y; Kakizoe T; Samma S; Oyasu R
    Cancer Res; 1987 Dec; 47(23):6176-9. PubMed ID: 3119193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Ohtani M; Kakizoe T; Nishio Y; Sato S; Sugimura T; Fukushima S; Niijima T
    Cancer Res; 1986 Apr; 46(4 Pt 2):2001-4. PubMed ID: 3948177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M
    Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of 6-phenylhexyl isothiocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolic activation and lung tumorigenesis in rats.
    Hecht SS; Trushin N; Rigotty J; Carmella SG; Borukhova A; Akerkar S; Desai D; Amin S; Rivenson A
    Carcinogenesis; 1996 Sep; 17(9):2061-7. PubMed ID: 8824535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fleroxacin on mouse bladder carcinogenesis with N-butyl-N- (4-hydroxybutyl) nitrosamine.
    Ebisuno S; Nishikawa T; Kohjimoto Y; Nishihata M; Inagaki T; Watanabe T; Ohkawa T
    Urol Int; 1999; 62(3):150-4. PubMed ID: 10529665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of enhancement of esophageal tumorigenesis by 6-phenylhexyl isothiocyanate.
    Morse MA; Lu J; Gopalakrishnan R; Peterson LA; D'Ambrosio SM; Wani G; Stoner GD
    Cancer Lett; 1997 Jan; 112(1):119-25. PubMed ID: 9029177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of urinary potassium and sodium ion concentrations and pH on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats.
    Lina BA; Woutersen RA
    Carcinogenesis; 1989 Sep; 10(9):1733-6. PubMed ID: 2548752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
    Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delay of bladder cancer induction in rats treated with N-nitroso-N-butyl-N-(4-hydroxybutyl)amine by administration of sodium-2-mercaptoethanesulfonate (Mesna).
    Tacchi AM; Schmähl D; Habs M
    Cancer Lett; 1984 Feb; 22(1):89-94. PubMed ID: 6421479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis.
    Masuda C; Wanibuchi H; Sekine K; Yano Y; Otani S; Kishimoto T; Tsuda H; Fukushima S
    Jpn J Cancer Res; 2000 Jun; 91(6):582-8. PubMed ID: 10874209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kitahori Y; Konishi N; Shimoyama T; Hiasa Y
    Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.